Finance

Beta
Lists
BNXT:CNSX
BioNxt Solutions Inc
CA$0.42
-4.55%
(-0.020) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BNXT...
Open
CA$0.42
High
CA$0.42
Low
CA$0.42
Mkt. cap
51.44M
Avg. vol.
20.11K
Volume
9.00K
52-wk high
CA$1.10
52-wk low
CA$0.34
EPS
-CA$0.08
No. of employees
20
Open
CA$0.42
High
CA$0.42
Low
CA$0.42
Mkt. cap
51.44M
Avg. vol.
20.11K
Volume
9.00K
52-wk high
CA$1.10
52-wk low
CA$0.34
EPS
-CA$0.08
No. of employees
20
News stories
From sources across the web
About BioNxt Solutions Inc
CEO-
Employees20
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitebionxt.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
11.26K
-11.26K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
315.79K
137.70K
190.50K
89.15K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
505.34K
997.10K
1.05M
668.41K
Operating expense
1.08M
1.28M
1.73M
2.78M
Total operating expenses
1.08M
1.28M
1.73M
2.78M
Operating income
-1.08M
-1.27M
-1.75M
-2.78M
Other non operating income
-45.84K
-27.60K
-24.60K
-11.40K
EBT including unusual items
-1.30M
-1.60M
-2.34M
-4.25M
EBT excluding unusual items
-1.30M
-1.56M
-2.32M
-3.18M
Income tax expense
-
-
-197.47K
-
Effective tax rate
-
-
8.42%
-
Other operating expenses
-
-
-
-
Net income
-1.30M
-1.60M
-2.15M
-4.25M
Net profit margin
-
-14,248.03%
19,073.55%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-383.79K
-380.64K
-422.10K
-369.04K
Net interest expenses
-383.79K
-380.64K
-422.10K
-369.04K
Depreciation and amortization charges
6.82K
5.55K
4.49K
1.06K
EBITDA
-1.08M
-1.26M
-1.74M
-2.78M
Gain or loss from assets sale
-236.00
-15.11K
69.62K
-61.94K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more